Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Decontamination and management of contaminated hair following a CBRN incident.

Matar H, Pinhal A, Amer N, Barrett M, Thomas E, Hughes P, Larner J, Chilcott RP.

Toxicol Sci. 2019 Jun 26. pii: kfz145. doi: 10.1093/toxsci/kfz145. [Epub ahead of print]

PMID:
31241158
2.

UK's initial operational response and specialist operational response to CBRN and HazMat incidents: a primer on decontamination protocols for healthcare professionals.

Chilcott RP, Larner J, Matar H.

Emerg Med J. 2019 Feb;36(2):117-123. doi: 10.1136/emermed-2018-207562. Epub 2018 Dec 1.

3.

Hybrid in vitro diffusion cell for simultaneous evaluation of hair and skin decontamination: temporal distribution of chemical contaminants.

Matar H, Amer N, Kansagra S, Pinhal A, Thomas E, Townend S, Larner J, Chilcott RP.

Sci Rep. 2018 Nov 15;8(1):16906. doi: 10.1038/s41598-018-35105-z.

4.

Further studies of the efficacy of military, commercial and novel skin decontaminants against the chemical warfare agents sulphur Mustard, Soman and VX.

Matar H, Price SC, Chilcott RP.

Toxicol In Vitro. 2019 Feb;54:263-268. doi: 10.1016/j.tiv.2018.10.008. Epub 2018 Oct 19.

PMID:
30347232
5.

Evaluation of US Federal Guidelines (Primary Response Incident Scene Management [PRISM]) for Mass Decontamination of Casualties During the Initial Operational Response to a Chemical Incident.

Chilcott RP, Larner J, Durrant A, Hughes P, Mahalingam D, Rivers S, Thomas E, Amer N, Barrett M, Matar H, Pinhal A, Jackson T, McCarthy-Barnett K, Reppucci J.

Ann Emerg Med. 2019 Jun;73(6):671-684. doi: 10.1016/j.annemergmed.2018.06.042. Epub 2018 Aug 23.

6.

Sebomic identification of sex- and ethnicity-specific variations in residual skin surface components (RSSC) for bio-monitoring or forensic applications.

Shetage SS, Traynor MJ, Brown MB, Chilcott RP.

Lipids Health Dis. 2018 Aug 21;17(1):194. doi: 10.1186/s12944-018-0844-z.

7.

Optimization of Nonambulant Mass Casualty Decontamination Protocols as Part of an Initial or Specialist Operational Response to Chemical Incidents.

Chilcott RP, Mitchell H, Matar H.

Prehosp Emerg Care. 2018 May 30:1-12. doi: 10.1080/10903127.2018.1469705. [Epub ahead of print]

PMID:
29847186
8.

Eyeing up the Future of the Pupillary Light Reflex in Neurodiagnostics.

Hall CA, Chilcott RP.

Diagnostics (Basel). 2018 Mar 13;8(1). pii: E19. doi: 10.3390/diagnostics8010019. Review.

9.

Octodrine: New Questions and Challenges in Sport Supplements.

Catalani V, Prilutskaya M, Al-Imam A, Marrinan S, Elgharably Y, Zloh M, Martinotti G, Chilcott R, Corazza O.

Brain Sci. 2018 Feb 20;8(2). pii: E34. doi: 10.3390/brainsci8020034.

10.

Demonstration of universal parametric entangling gates on a multi-qubit lattice.

Reagor M, Osborn CB, Tezak N, Staley A, Prawiroatmodjo G, Scheer M, Alidoust N, Sete EA, Didier N, da Silva MP, Acala E, Angeles J, Bestwick A, Block M, Bloom B, Bradley A, Bui C, Caldwell S, Capelluto L, Chilcott R, Cordova J, Crossman G, Curtis M, Deshpande S, El Bouayadi T, Girshovich D, Hong S, Hudson A, Karalekas P, Kuang K, Lenihan M, Manenti R, Manning T, Marshall J, Mohan Y, O'Brien W, Otterbach J, Papageorge A, Paquette JP, Pelstring M, Polloreno A, Rawat V, Ryan CA, Renzas R, Rubin N, Russel D, Rust M, Scarabelli D, Selvanayagam M, Sinclair R, Smith R, Suska M, To TW, Vahidpour M, Vodrahalli N, Whyland T, Yadav K, Zeng W, Rigetti CT.

Sci Adv. 2018 Feb 2;4(2):eaao3603. doi: 10.1126/sciadv.aao3603. eCollection 2018 Feb.

11.

The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.

Lydon H, Hall C, Matar H, Dalton C, Chipman JK, Graham JS, Chilcott RP.

J Appl Toxicol. 2018 Mar;38(3):318-328. doi: 10.1002/jat.3542. Epub 2017 Oct 10.

PMID:
29023806
12.

The percutaneous absorption of soman in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.

Dalton C, Hall C, Lydon H, Jenner J, Chipman JK, Graham JS, Chilcott RP.

Cutan Ocul Toxicol. 2018 Jun;37(2):172-179. doi: 10.1080/15569527.2017.1365883. Epub 2017 Aug 30.

PMID:
28853336
13.

Application of sebomics for the analysis of residual skin surface components to detect potential biomarkers of type-1 diabetes mellitus.

Shetage SS, Traynor MJ, Brown MB, Galliford TM, Chilcott RP.

Sci Rep. 2017 Aug 21;7(1):8999. doi: 10.1038/s41598-017-09014-6.

14.

Volunteer trials of a novel improvised dry decontamination protocol for use during mass casualty incidents as part of the UK'S Initial Operational Response (IOR).

Amlôt R, Carter H, Riddle L, Larner J, Chilcott RP.

PLoS One. 2017 Jun 16;12(6):e0179309. doi: 10.1371/journal.pone.0179309. eCollection 2017.

15.

Hair analysis for the detection of drug use-is there potential for evasion?

Marrinan S, Roman-Urrestarazu A, Naughton D, Levari E, Collins J, Chilcott R, Bersani G, Corazza O.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2587. Epub 2017 May 31. Review.

PMID:
28568705
16.

The percutaneous toxicokinetics of Sulphur mustard in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.

Hall CA, Lydon HL, Dalton CH, Chipman JK, Graham JS, Chilcott RP.

J Appl Toxicol. 2017 Sep;37(9):1036-1045. doi: 10.1002/jat.3453. Epub 2017 Mar 17.

PMID:
28304107
17.

Development of haemostatic decontaminants for treatment of wounds contaminated with chemical warfare agents. 3: Evaluation of in vitro topical decontamination efficacy using damaged skin.

Lydon HL, Hall CA, Dalton CH, Chipman JK, Graham JS, Chilcott RP.

J Appl Toxicol. 2017 Aug;37(8):976-984. doi: 10.1002/jat.3446. Epub 2017 Feb 20.

PMID:
28218409
18.

Evaluation of absorbent materials for use as ad hoc dry decontaminants during mass casualty incidents as part of the UK's Initial Operational Response (IOR).

Kassouf N, Syed S, Larner J, Amlôt R, Chilcott RP.

PLoS One. 2017 Feb 2;12(2):e0170966. doi: 10.1371/journal.pone.0170966. eCollection 2017.

19.

Evaluation of a new topical skin protectant (RD1433) for the prevention and treatment of incontinence-associated dermatitis.

Matar H, Larner J, Viegas V, Kansagra S, Atkinson KL, Shetage S, Skamarauskas JT, Theivendran B, Goldman VS, Chilcott RP.

Cutan Ocul Toxicol. 2017 Sep;36(3):211-219. doi: 10.1080/15569527.2016.1257637. Epub 2016 Nov 23.

PMID:
27817210
20.

Captagon: use and trade in the Middle East.

Al-Imam A, Santacroce R, Roman-Urrestarazu A, Chilcott R, Bersani G, Martinotti G, Corazza O.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2548. Epub 2016 Oct 21. Review.

PMID:
27766667
21.

Mass Casualty Decontamination in the United States: An Online Survey of Current Practice.

Power S, Symons C, Carter H, Jones E, Amlôt R, Larner J, Matar H, Chilcott RP.

Health Secur. 2016 Jul-Aug;14(4):226-36. doi: 10.1089/hs.2016.0047. Epub 2016 Jul 21.

22.

Preliminary evaluation of military, commercial and novel skin decontamination products against a chemical warfare agent simulant (methyl salicylate).

Matar H, Guerreiro A, Piletsky SA, Price SC, Chilcott RP.

Cutan Ocul Toxicol. 2016;35(2):137-44. doi: 10.3109/15569527.2015.1072544. Epub 2015 Aug 13.

PMID:
26339920
23.

Preliminary evaluation of military, commercial and novel skin decontamination products against a chemical warfare agent simulant (methyl salicylate).

Matar H, Guerreiro A, Piletsky SA, Price SC, Chilcott RP.

Cutan Ocul Toxicol. 2015 Aug 13:1-8. [Epub ahead of print]

PMID:
26271021
24.

Optimisation of a dosing regime for a topical skin protectant (barrier cream).

Chilcott RP, Larner J, Matar H, Kansagra S, Theivendran B, Viegas VA, Goldman VS.

Cutan Ocul Toxicol. 2015;34(4):327-34. doi: 10.3109/15569527.2014.994124. Epub 2015 Jan 19.

PMID:
25597377
25.

Development of a cumulative irritation model for incontinence-associated dermatitis.

Larner J, Matar H, Goldman VS, Chilcott RP.

Arch Dermatol Res. 2015 Jan;307(1):39-48. doi: 10.1007/s00403-014-1526-y. Epub 2014 Nov 22.

PMID:
25416151
26.

Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 2: evaluation of in vitro topical decontamination efficacy using undamaged skin.

Dalton CH, Hall CA, Lydon HL, Chipman JK, Graham JS, Jenner J, Chilcott RP.

J Appl Toxicol. 2015 May;35(5):543-50. doi: 10.1002/jat.3060. Epub 2014 Sep 12.

PMID:
25219755
27.

Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1: evaluation of in vitro clotting efficacy in the presence of certain contaminants.

Hall CA, Lydon HL, Dalton CH, Chipman JK, Graham JS, Chilcott RP.

J Appl Toxicol. 2015 May;35(5):536-42. doi: 10.1002/jat.3019. Epub 2014 Aug 15.

PMID:
25131713
28.

Managing mass casualties and decontamination.

Chilcott RP.

Environ Int. 2014 Nov;72:37-45. doi: 10.1016/j.envint.2014.02.006. Epub 2014 Mar 29. Review.

PMID:
24684820
29.

Recent advances to address European Union Health Security from cross border chemical health threats.

Duarte-Davidson R, Orford R, Wyke S, Griffiths M, Amlôt R, Chilcott R.

Environ Int. 2014 Nov;72:3-14. doi: 10.1016/j.envint.2014.01.003. Epub 2014 Mar 27.

PMID:
24679379
30.

Design and characterisation of a novel in vitro skin diffusion cell system for assessing mass casualty decontamination systems.

Matar H, Larner J, Kansagra S, Atkinson KL, Skamarauskas JT, Amlot R, Chilcott RP.

Toxicol In Vitro. 2014 Jun;28(4):492-501. doi: 10.1016/j.tiv.2014.01.001. Epub 2014 Jan 8.

PMID:
24412538
31.

Effect of ethnicity, gender and age on the amount and composition of residual skin surface components derived from sebum, sweat and epidermal lipids.

Shetage SS, Traynor MJ, Brown MB, Raji M, Graham-Kalio D, Chilcott RP.

Skin Res Technol. 2014 Feb;20(1):97-107. doi: 10.1111/srt.12091. Epub 2013 Jul 19.

32.

In vivo decontamination of the nerve agent VX using the domestic swine model.

Misik J, Pavlik M, Novotny L, Pavlikova R, Chilcott RP, Cabal J, Kuca K.

Clin Toxicol (Phila). 2012 Nov;50(9):807-11. doi: 10.3109/15563650.2012.720986. Epub 2012 Sep 11.

PMID:
22963275
33.

Ga(III) complexes--the effect of metal coordination on potential systemic absorption after topical exposure.

Staff K, Brown MB, Chilcott RP, Hider RC, Jones SA, Kong XL.

Toxicol Lett. 2011 May 10;202(3):155-60. doi: 10.1016/j.toxlet.2011.01.017. Epub 2011 Feb 17.

PMID:
21315140
34.

Comparative analysis of showering protocols for mass-casualty decontamination.

Amlot R, Larner J, Matar H, Jones DR, Carter H, Turner EA, Price SC, Chilcott RP.

Prehosp Disaster Med. 2010 Sep-Oct;25(5):435-9.

PMID:
21053192
35.

The skin reservoir of sulphur mustard.

Hattersley IJ, Jenner J, Dalton C, Chilcott RP, Graham JS.

Toxicol In Vitro. 2008 Sep;22(6):1539-46. doi: 10.1016/j.tiv.2008.06.002. Epub 2008 Jun 14.

PMID:
18598749
36.

Decontamination of multiple casualties who are chemically contaminated: a challenge for acute hospitals.

Clarke SF, Chilcott RP, Wilson JC, Kamanyire R, Baker DJ, Hallett A.

Prehosp Disaster Med. 2008 Mar-Apr;23(2):175-81. Review.

PMID:
18557298
37.

Evaluation of barrier creams against sulphur mustard: (II) In vivo and in vitro studies using the domestic white pig.

Chilcott RP, Dalton CH, Ashley Z, Allen CE, Bradley ST, Maidment MP, Jenner J, Brown RF, Gwyther RJ, Rice P.

Cutan Ocul Toxicol. 2007;26(3):235-47.

PMID:
17687688
38.

Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies.

Graham JS, Chilcott RP, Rice P, Milner SM, Hurst CG, Maliner BI.

J Burns Wounds. 2005 Jan 5;4:e1.

39.

Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro.

Dalton CH, Hattersley IJ, Rutter SJ, Chilcott RP.

Toxicol In Vitro. 2006 Dec;20(8):1532-6. Epub 2006 Jul 8.

PMID:
16904285
40.

Closed cup vapor systems in percutaneous exposure studies: what is the dose?

Dalton CH, Maidment MP, Jenner J, Chilcott RP.

J Anal Toxicol. 2006 Apr;30(3):165-70.

PMID:
16803650
41.

In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig.

Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED, Hamilton MG.

Hum Exp Toxicol. 2005 Jul;24(7):347-52.

PMID:
16119248
42.

Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig.

Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED, Hamilton MG.

Basic Clin Pharmacol Toxicol. 2005 Jul;97(1):35-8.

43.

Toxicity of sulphur mustard.

Chilcott RP.

Toxicol Appl Pharmacol. 2005 Apr 1;204(1):99-100; author reply 100. No abstract available.

PMID:
15781298
44.

Inter- and intralaboratory variation of in vitro diffusion cell measurements: an international multicenter study using quasi-standardized methods and materials.

Chilcott RP, Barai N, Beezer AE, Brain SI, Brown MB, Bunge AL, Burgess SE, Cross S, Dalton CH, Dias M, Farinha A, Finnin BC, Gallagher SJ, Green DM, Gunt H, Gwyther RL, Heard CM, Jarvis CA, Kamiyama F, Kasting GB, Ley EE, Lim ST, McNaughton GS, Morris A, Nazemi MH, Pellett MA, Du Plessis J, Quan YS, Raghavan SL, Roberts M, Romonchuk W, Roper CS, Schenk D, Simonsen L, Simpson A, Traversa BD, Trottet L, Watkinson A, Wilkinson SC, Williams FM, Yamamoto A, Hadgraft J.

J Pharm Sci. 2005 Mar;94(3):632-8.

PMID:
15666298
45.

Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig.

Chilcott RP, Dalton CH, Hill I, Davidson CM, Blohm KL, Hamilton MG.

Hum Exp Toxicol. 2003 May;22(5):255-61.

PMID:
12774888
46.

Evaluation of barrier creams against sulphur mustard. I. In vitro studies using human skin.

Chilcott RP, Jenner J, Hotchkiss SA, Rice P.

Skin Pharmacol Appl Skin Physiol. 2002 Jul-Aug;15(4):225-35.

PMID:
12218284
47.

Transepidermal water loss does not correlate with skin barrier function in vitro.

Chilcott RP, Dalton CH, Emmanuel AJ, Allen CE, Bradley ST.

J Invest Dermatol. 2002 May;118(5):871-5.

48.

In vitro skin absorption and decontamination of sulphur mustard: comparison of human and pig-ear skin.

Chilcott RP, Jenner J, Hotchkiss SA, Rice P.

J Appl Toxicol. 2001 Jul-Aug;21(4):279-83.

PMID:
11481660
49.

Habituating pigs for in-pen, non-invasive biophysical skin analysis.

Chilcott RP, Stubbs B, Ashley Z.

Lab Anim. 2001 Jul;35(3):230-5.

PMID:
11459406
50.

Supplemental Content

Loading ...
Support Center